Isolated Common Iliac Artery Aneurysms Treated Solely With Iliac Branch Stent-Grafts: Midterm Results of a Multicenter Registry

• Published in: Journal of endovascular therapy 2018-04, Vol.25 (2), p.169-177
• Main Authors: Giaquinta, Alessia, Ardita, Vincenzo, Ferrer, Ciro, Beggs, Clive B., Veroux, Massimiliano, Barbante, Matteo, Orrico, Matteo, Cao, Piergiorgio, Veroux, Piefrancesco, Mangialardi, Nicola, Ronchey, Sonia, Lenti, Massimo, Verzini, Fabio, Parlani, Gianbattista, Ippoliti, Arnaldo, Pratesi, Giovanni, Coscarella, Carlo, Setacci, Carlo, de Donato, Gianmarco, Galzerano, Giuseppe, Pratesi, Carlo, Fargion, Aaron, Veroux, Chiara, Mociskyte, Dovile, De Marco, Ester, Virgilio, Carla, Virgilio, Vittorio
• Format: Article
• Language: English
• ISSN: 1526-6028; 1545-1550
• DOI: 10.1177/1526602818754862

Purpose: To assess early and midterm outcomes of iliac branch device (IBD) implantation without an aortic stent-graft for the treatment of isolated common iliac artery aneurysm (CIAA). Methods: From December 2006 to June 2016, 49 isolated CIAAs in 46 patients were treated solely with an IBD at 7 vascular centers. Five patients were lost to follow-up, leaving 41 male patients (mean age 72.5±7.8 years) for analysis. Mean CIAA diameter was 39.1±10.5 mm (range 25–65). Thirty-two patients (2 with bilateral CIAAs) were treated with a Cook Zenith iliac branch device; 9 patients (1 bilateral) received a Gore Excluder iliac branch endoprosthesis. Primary endpoints were technical success, survival, aneurysm exclusion, device patency, and freedom from reintervention at 1 and 5 years. Freedom from major adverse events and aneurysm shrinkage at 1 year were also assessed. Results: Thirty-day mortality and the IBD occlusion rate were 2.4% and 2.3%, respectively. At a mean follow-up of 40.2±33.9 months, no patient presented buttock claudication, erectile dysfunction, or bowel or spinal cord ischemia. Three patients died within 6 months after the procedure. Estimates of cumulative survival, device patency, and freedom from reintervention were 90.2%, 95.2%, and 95.7%, respectively, at 1 and 5 years. At 1 year, CIAA shrinkage ≥5 mm was recorded in 21 of 38 survivors. No evidence of endoleak, device migration, or disconnection was found on imaging follow-up. Conclusion: The use of IBDs without an aortic stent-graft for isolated CIAAs resulted in excellent patency, with low morbidity and mortality. This, in conjunction with no endoleak or migration and a low reintervention rate, supports the use of isolated IBDs as a stable and durable means of endovascular reconstruction in cases with suitable anatomy. Longer follow-up and a larger cohort are needed to validate these results.